Study: Donanemab Significantly Reduces Cognitive, Functional Decline Associated With Alzheimer Disease - Pharmacy Times
- Study: Donanemab Significantly Reduces Cognitive, Functional Decline Associated With Alzheimer Disease Pharmacy Times
- Alzheimer’s patient: New ‘miracle’ drug has ‘given me my life back’ New York Post
- New Alzheimer's treatment: Donanemab drug seen as turning point in fight against disease FRANCE 24 English
- Eli Lilly says FDA approval of Alzheimer’s drug donanemab could come later this year Fox Business
- More developments being made in Alzheimer's research WBAL-TV 11 Baltimore
- View Full Coverage on Google News